Business
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Md., March 28, 2022\n\n\n\nTEL AVIV, Israel and BETHESDA, Md., March 28, 2022 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has changed its corporate name to \"CNBX Pharmaceuticals Inc.\"\nThe Company's new brand identity reflects the significant transformation that has already taken place across the Company's platform, as well as the team's forward-looking approach to molecule-based drug development for the treatment of colorectal cancer, and in preparation of a Phase I/II (a) clinical validation study for its proprietary RCC-33 drug candidate. \nThe Company is in the process of developing a new corporate website and updated social media accounts reflecting the new corporate company name. The new website, www.cnbxpharma.com, and the updated social media accounts, are expected to go live by April 1st, 2022.\nThe Company's stock will continue trading under the ticker OTCQB: CNBX. The corporate name change to CNBX Pharmaceuticals Inc. does not affect the rights of the company's stockholders and no action is required by stockholders with respect to the name change.  Outstanding stock certificates are not affected by the name change and will not need to be exchanged. \nAbout CNBX Pharmaceuticals:\nCNBX Pharmaceuticals Inc.  is a U.S. public company and a global leader in the development of cancer related cannabinoid-based medicine. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer. For more information, please visit www.cannabics.com. For the latest updates on CNBX Pharmaceuticals follow the Company on Twitter @Cannabics, Facebook @CannabicsPharmaceuticals, LinkedIn, and on Inst...